CoChat

A Microfluidic Platform for Systems Pathology: Multiparameter Single-Cell Signaling Measurements of Clinical Brain Tumor Specimens

Open access
Sun, Jing, Masterman-Smith, Michael D., Graham, Nicholas A., Jiao, Jing, Mottahedeh, Jack, Laks, Dan R., Ohashi, Minori, DeJesus, Jason, Kamei, Ken-ichiro, Lee, Ki-Bum, Wang, Hao, Yu, Zeta T.F., Lu, Yi-Tsung, Hou, Shuang, Li, Keyu, Liu, Max, Zhang, Nangang, Wang, Shutao, Angenieux, Brigitte, Panosyan, Eduard, Samuels, Eric R., Park, Jun, Williams, Dirk, Konkankit, Vera, Nathanson, David, van Dam, R. Michael, Phelps, Michael E., Wu, Hong, Liau, Linda M., Mischel, Paul S., Lazareff, Jorge A., Kornblum, Harley I., Yong, William H., Graeber, Thomas G., Tseng, Hsian-Rong · 2010 · Cancer Research
Cited by 112

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The clinical practice of oncology is being transformed by molecular diagnostics that will enable predictive and personalized medicine. Current technologies for quantitation of the cancer proteome are either qualitative (e.g., immunohistochemistry) or require large sample sizes (e.g., flow cytometry). Here, we report a microfluidic platform—microfluidic image cytometry (MIC)—capable of quantitative, single-cell proteomic analysis of multiple signaling molecules using only 1,000 to 2,800 cells. Using cultured cell lines, we show simultaneous measurement of four critical signaling proteins (EGFR, PTEN, phospho-Akt, and phospho-S6) within the oncogenic phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway. To show the clinical application of the MIC platform to solid tumors, we analyzed a panel of 19 human brain tumor biopsies, including glioblastomas. Our MIC measurements were validated by clinical immunohistochemistry and confirmed the striking intertumoral and intratumoral heterogeneity characteristic of glioblastoma. To interpret the multiparameter, single-cell MIC measurements, we adapted bioinformatic methods including self-organizing maps that stratify patients into clusters that predict tumor progression and patient survival. Together with bioinformatic analysis, the MIC platform represents a robust, enabling in vitro molecular diagnostic technology for systems pathology analysis and personalized medicine. Cancer Res; 70(15); 6128–38. ©2010 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-10-0076

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 112

Metadata

Authors
Sun, J., Masterman-Smith, M. D., Graham, N. A., Jiao, J., Mottahedeh, J., Laks, D. R., Ohashi, M., DeJesus, J., Kamei, K.-I., Lee, K.-B., Wang, H., Yu, Z. T. F., Lu, Y.-T., Hou, S., Li, K., Liu, M., Zhang, N., Wang, S., Angenieux, B., Panosyan, E., Samuels, E. R., Park, J., Williams, D., Konkankit, V., Nathanson, D., van Dam, R. M., Phelps, M. E., Wu, H., Liau, L. M., Mischel, P. S., Lazareff, J. A., Kornblum, H. I., Yong, W. H., Graeber, T. G., & Tseng, H.-R.
Venue
Cancer Research
Published
2010-07-28
Volume
70
Issue
15
Pages
6128-6138
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2144265476
Cited by
112
References
5
FWCI
8.56
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Microfluidic Platform for Systems Pathology: Multiparameter Single-Cell Signaling Measurements of Clinical Brain Tumor Specimens. https://app.cochat.ai/papers/10.1158/0008-5472.can-10-0076
The paper
Sun, J., Masterman-Smith, M. D., Graham, N. A., Jiao, J., Mottahedeh, J., Laks, D. R., Ohashi, M., DeJesus, J., Kamei, K.-I., Lee, K.-B., Wang, H., Yu, Z. T. F., Lu, Y.-T., Hou, S., Li, K., Liu, M., Zhang, N., Wang, S., Angenieux, B., . . . Tseng, H.-R. (2010). A Microfluidic Platform for Systems Pathology: Multiparameter Single-Cell Signaling Measurements of Clinical Brain Tumor Specimens. Cancer Research. https://doi.org/10.1158/0008-5472.can-10-0076

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.